Ovarian ablation as adjuvant therapy for premenopausal women with breast cancer--another step forward.
Pater
Joseph L
JL
Parulekar
Wendy R
WR
D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D017273:Goserelin / Q000627:therapeutic use*; D006801:Humans; D007391:International Cooperation; D008727:Methotrexate / Q000008:administration & dosage; D015337:Multicenter Studies as Topic; D010053:Ovary / Q000187:drug effects*; D017697:Premenopause
D018931:Antineoplastic Agents, Hormonal; D017273:Goserelin; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate